The Fibroblast Growth Factor 21 (FGF21) is considered an attractive therapeutic target for
obesity and obesity-related disorders due to its beneficial effects in lipid and carbohydrate …

Fibroblast growth factor 21 (FGF21) is in biomedical focus as a treatment option for
metabolic diseases, given that administration improves metabolism in mice and humans …

Dietary protein restriction has been demonstrated to improve metabolic health under various
conditions. However, the relevance of ageing and age‐related decline in metabolic flexibility …

The black bean is a legume widely consumed in Latin America, however its consumption
has decreased significantly in recent decades. There is evidence that its consumption …

Abstract Aim Glucocorticoids (GCs) play a crucial role in energy homeostasis including white
adipose tissue function; however, chronic GC excess is detrimental to mammals' health …

Browning of white adipocytes (WAs)(also referred as beige cells) was demonstrated to
execute thermogenesis by consuming stored lipids as do brown adipocytes (BAs), and this …

Aim An adverse endogenous environment during early life predisposes to metabolic
disorder development. We previously reported adverse metabolic and adipose tissue effects …

Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve
metabolic health and extend the life span of mice and humans. However, most studies …

Nuestra hipótesis a ser puesta a prueba se basa en que “la castración prepuberal en la rata
hembra provoca el desarrollo anormal del tejido adiposo blanco, lo cual genera un impacto …

Several studies have shown a relationship between the distribution of fat mass around the
organism, metabolic disorders, and an increased risk of morbidity and mortality. It has been …